United States
Novadiol Co Sa is a biopharmaceutical company headquartered in Kansas City and was founded in 2012. The company develops patent-protected medications, particularly for patients with kidney diseases. Their late-stage development project Dendocrin™ is a newer approach to treating secondary hyperparathyroidism (SHPT) in patients with stage 3 and 4 chronic kidney disease (CKD). Novadiol has strong worldwide patent rights, reduces development costs by utilizing the 505(b)(2) regulatory pathway in the USA, and offers a patient-friendly, cost-effective therapy. The company works with experienced pharmaceutical experts to develop innovative products for patients with kidney diseases.
Browsing, company names, locations and sectors are always free. A free account adds 5 contact releases every month — e-mail and phone, view or export. Need more? Contact packs start at 19 € for 50, or upgrade to a monthly plan.
Yes — no card required. Browsing is always free, and a free account adds 5 contact releases every month.
Your first 5 contact releases each month are included in the free account. After that, packs start at 19 € for 50 contacts (view or export), or a monthly plan for regular use.
Companies are harvested from the open web — registers, websites and industry directories — not self-registered sign-ups. Contact details are shown only once you use a release or credit, never invented.